GSK statement in response to patent ruling reversal on Lovaza

GlaxoSmithKline confirmed today that the Court of Appeals for the Federal Circuit has ruled against Pronova Biopharma Norge AS in its patent litigation regarding Lovaza® (omega-3-acid ethyl esters).
Source: GSK news - Category: Pharmaceuticals Source Type: news